542 results on '"M Yoshii"'
Search Results
2. 15 alpha-hydroxylation of a bile acid analogue, sodium 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate in the hamster.
- Author
-
T Mikami, A Ohshima, E H Mosbach, B I Cohen, N Ayyad, M Yoshii, K Ohtani, K Kihira, C D Schteingart, and T Hoshita
- Subjects
Biochemistry ,QD415-436 - Abstract
The metabolism of 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate (bishomoCDC-sul), the sulfonate analogue of bishomochenodeoxycholic acid, and its effect on biliary bile acid composition were studied during chronic administration in the hamster. After oral administration of radiolabeled bishomoCDC-sul, more than 80% of the radioactivity was excreted into the feces within 7 days, both as the unchanged sulfonate (38.5%) and two more polar metabolites (50.0% and 11.5%). The half time of the fecal excretion was 1.6 days. In gallbladder bile, the unchanged sulfonate and its major metabolite accounted for 19.1% and 19.8% of total bile acids, respectively. In another experiment, hamsters were fed bishomoCDC-sul with antibiotics to evaluate the site of biotransformation. Even when the number of intestinal microorganisms was greatly reduced, the same three metabolites were found in the feces: bishomoCDC-sul (44.0%) and the two polar metabolites (30.8% and 25.1%). The major metabolite was isolated from feces of the hamsters fed bishomoCDC-sul without antibiotics. Its chemical structure was identified by mass spectrometry and nuclear magnetic resonance spectroscopy as the 15 alpha-hydroxylated derivative, namely sodium 3 alpha,7 alpha,15 alpha-trihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate. These results indicate that after oral administration, the sulfonate analogue of bishomochenodeoxycholic acid underwent enterohepatic circulation like a natural bile acid and was transformed, in part, into the 15 alpha-hydroxylated derivative and another more polar metabolite in the liver of hamsters. There was no evidence that bishomoCDC-sul was dehydroxylated to a lithocholic acid analogue during enterohepatic cycling.
- Published
- 1996
- Full Text
- View/download PDF
3. Effect of some sulfonate analogues of ursodeoxycholic acid on biliary lipid secretion in the rat.
- Author
-
T Mikami, K Kihira, S Ikawa, M Yoshii, E H Mosbach, and T Hoshita
- Subjects
Biochemistry ,QD415-436 - Abstract
The effect of the sulfonate analogues of ursodeoxycholic acid, namely sodium 3 alpha,7 beta-dihydroxy-24-nor-5 beta-cholane-23-sulfonate (norUDC-SO3Na) and sodium 3 alpha, 7 beta-dihydroxy-5 beta-cholane-24-sulfonate (UDC-SO3Na), on biliary lipid secretion was studied in bile fistula rats. During intravenous infusion of the two sulfonate analogues, bile flow and biliary lipid secretion were stimulated in a dose-dependent manner. This suggests that the analogues exert an effect on biliary lipid secretion comparable to that of the naturally occurring bile acid, ursodeoxycholyltaurine (UDC-tau). The effects of norUDC-SO3Na and UDC-SO3Na on bile flow were similar but slightly smaller than that of UDC-tau. The output of bile salts was similar with both sulfonates but greater than that with UDC-tau. The infusion of norUDC-SO3Na or UDC-SO3Na induced cholesterol secretion and phospholipid secretion more significantly than UDC-tau infusion. The increase in phospholipid secretion was particularly pronounced during high-dose administration of norUDC-SO3Na. Although norUDC-SO3Na stimulated cholesterol secretion more intensely than the other two bile salts, it also facilitated phospholipid output, perhaps as a compensatory mechanism, and the biliary cholesterol/phospholipid ratio was decreased to a greater extent by the sulfonates than by UDC-tau. Consequently, the administration of norUDC-SO3Na or UDC-SO3Na produces a more “stable” bile than UDC-tau, suggesting that these sulfonates possess potential cholelitholytic activity.
- Published
- 1996
- Full Text
- View/download PDF
4. Bile salts of the toad, Bufo marinus: characterization of a new unsaturated higher bile acid, 3 alpha,7 alpha,12 alpha,26-tetrahydroxy-5 beta-cholest-23-en-27-oic acid.
- Author
-
M Yoshii, M Une, K Kihira, T Kuramoto, T Akizawa, M Yoshioka, V P Butler, Jr., and T Hoshita
- Subjects
Biochemistry ,QD415-436 - Abstract
The bile salts present in gallbladder bile of the toad, Bufo marinus, were found to consist of a mixture of bile alcohol sulfates and unconjugated bile acids. The major bile alcohol was 5 beta-bufol; 5 alpha- and 5 beta-cholestane-3 alpha,7 alpha,12 alpha, 26-tetrols occurred as the minor bile alcohols. Bile acids of Bufo marinus were cholic acid, allocholic acid, 3 alpha,7 alpha,12 alpha-trihydroxy-5 alpha- and 5 beta-cholestan-26-oic acids, 3 alpha,7 alpha,12 alpha-trihydroxy-5 alpha- and 5 beta-cholest-23-en-26-oic acids, 3 alpha,7 alpha,12 alpha, 26-tetrahydroxy-5 beta-cholestan-27-oic acid, and a C27 bile acid which has not been previously described. By chromatographic behavior, mass spectral data, and identification of the products of catalytic hydrogenation and ozonolysis, the structure of the new higher bile acid was elucidated as 3 alpha,7 alpha,12 alpha,26-tetrahydroxy-5 beta-cholest-23-en-27-oic acid. The bile salt pattern of Bufo marinus closely resembles that of Bufo vulgaris formosus, except for the absence of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholest-22-ene-24-carboxylic acid, the major bile acid of the latter toad.
- Published
- 1994
- Full Text
- View/download PDF
5. Metabolism of sulfonate analogs of ursodeoxycholic acid and their effects on biliary bile acid composition in hamsters.
- Author
-
T Mikami, K Kihira, S Ikawa, M Yoshii, S Miki, EH Mosbach, and T Hoshita
- Subjects
Biochemistry ,QD415-436 - Abstract
The metabolism of sodium 3 alpha,7 beta-dihydroxy-5 beta-cholane-24-sulfonate and sodium 3 alpha,7 beta-dihydroxy-24-nor-5 beta-cholane-23-sulfonate was studied in hamsters. In bile fistula animals these sulfonate analogs of ursodeoxycholic acid were absorbed mainly from the terminal ileum and secreted rapidly into the bile without biotransformation or conjugation. After oral administration, the sulfonate analogs were excreted in the feces at the same rate as chenodeoxycholic acid and its metabolic products. The intestinal microorganisms transformed chenodeoxycholic acid largely into lithocholic acid; the sulfonate analogs were completely resistant to biotransformation. After a 2-week feeding period, the sulfonate analogs of ursodeoxycholic acid accounted for 24.0% and 16.9% of total biliary bile acids. These sulfonates did not affect the proportions of the natural bile acids in the bile, and the ratio of glycine-conjugated bile acids to taurine-conjugated bile acids was not altered by feeding the sulfonates. In contrast, when ursodeoxycholic acid was fed, the proportions of the natural bile acids and the glycine/taurine ratio were changed. These results suggest that the sulfonate analogs had no profound effect on endogenous bile acid metabolism and did not cause a depletion of the hepatic taurine pool during enterohepatic circulation. The sulfonates had no effect on intestinal cholesterol absorption and serum cholesterol levels.
- Published
- 1993
- Full Text
- View/download PDF
6. Sulfonate analogues of chenodeoxycholic acid: metabolism of sodium 3 alpha, 7 alpha-dihydroxy-25-homo-5 beta-cholane-25-sulfonate and sodium 3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholane-23-sulfonate in the hamster.
- Author
-
S Miki, EH Mosbach, BI Cohen, M Yoshii, N Ayyad, and CK McSherry
- Subjects
Biochemistry ,QD415-436 - Abstract
This report describes the chemical synthesis of a new bile acid analogue, namely, sodium 3 alpha, 7 alpha-dihydroxy-25-homo-5 beta-cholane-25-sulfonate from homochenodeoxycholic acid. The structure of the new compound was assigned by proton magnetic resonance and infrared spectrometry. Its metabolism was studied in the hamster in comparison with sodium 3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholane-23-sulfonate and sodium taurochenodeoxycholate. After intraduodenal administration of the 3H-labeled analogues into bile fistula hamsters, both sulfonates were absorbed from the intestine and nearly 80% of the radioactivity was secreted into bile within 8 h. Intra-ileal administration revealed that these compounds resembled taurochenodeoxycholate in that they were much more rapidly absorbed from the ileum than from the proximal small intestine: more than 85% of the radioactivity was recovered in bile within 1 h. After intravenous infusion the sulfonates were efficiently extracted by the liver at rates similar to that of sodium taurochenodeoxycholate. Chromatographic analysis of the bile showed that, regardless of the route of administration, most (> 95%) of the sulfonates were not biotransformed and they became major biliary bile acids. Sodium 3 alpha, 7 alpha-dihydroxy-25-homo-5 beta-cholane-25-sulfonate and, to a lesser extent, sodium 3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholane-23-sulfonate induced cholestasis at infusion rates at which sodium taurochenodeoxycholate produced choleresis.
- Published
- 1992
- Full Text
- View/download PDF
7. Chemical synthesis and hepatic biotransformation of 3 alpha,7 alpha-dihydroxy-7 beta-methyl-24-nor-5 beta-cholan-23-oic acid, a 7-methyl derivative of norchenodeoxycholic acid: studies in the hamster.
- Author
-
M Yoshii, EH Mosbach, CD Schteingart, LR Hagey, AF Hofmann, BI Cohen, and CK McSherry
- Subjects
Biochemistry ,QD415-436 - Abstract
A new bile acid analogue, 3 alpha,7 alpha-dihydroxy-7 beta-methyl-24-nor-5 beta-cholan-23-oic acid (7-Me-norCDCA) was synthesized from the methyl ester of norursodeoxycholic acid, and its hepatic biotransformation was defined in the hamster. To synthesize 7-Me-norCDCA, the 3 alpha-hydroxyl group of methyl norursodeoxycholate was protected as the hemisuccinate, and the 7 beta-hydroxyl group was oxidized with CrO3 to form the 7-ketone. A Grigard reaction with methyl magnesium iodide followed by alkaline hydrolysis gave 7-Me-norCDCA (greater than 70% yield). The structure of the new compound was confirmed by proton magnetic resonance and mass spectrometry. After intraduodenal administration of the 14C-labeled compound into the anesthetized biliary fistula hamster, it was rapidly and efficiently secreted into the bile; 80% of radioactivity was recovered in 2 h. After intravenous infusion, the compound was efficiently extracted by the liver and secreted into the bile (greater than 75% in 3 h). Most (93%) of the biliary radioactivity was present in biotransformation products. The major biotransformation product (48.7 +/- 6.0%) was a new compound, assigned the structure of 3 alpha,5 beta,7 alpha- trihydroxy-7 beta-methyl-24-nor-5 beta-cholan-23-oic acid (5 beta-hydroxy-7- Me-norCDCA). In addition, conjugates of 7-Me-norCDCA with taurine (13.7 +/- 5.0%), sulfate (10.3 +/- 3.0%), or glucuronide (5.1 +/- 1.7%) were formed. 7-Me-norCDCA was strongly choleretic in the hamster; during its intravenous infusion, bile flow increased 2 to 3 times above the basal level, and the calculated choleretic activity of the compound (and its metabolic products) was much greater than that of many natural bile acids, indicating that the compound induced hypercholeresis. It is concluded that the biotransformation and physiological properties of 7-Me-norCDCA closely resemble those of norCDCA. Based on previous studies, the major biological effect of the 7-methyl group in 7-Me-norCDCA is to prevent its bacterial 7-dehydroxylation in the distal intestine.
- Published
- 1991
- Full Text
- View/download PDF
8. Synthesis of new bile salt analogues, sodium 3 alpha, 7 alpha-dihydroxy-5 beta-cholane-24-sulfonate and sodium 3 alpha, 7 beta-dihydroxy-5 beta-cholane-24-sulfonate.
- Author
-
K Kihira, M Yoshii, A Okamoto, S Ikawa, H Ishii, and T Hoshita
- Subjects
Biochemistry ,QD415-436 - Abstract
This report describes the chemical synthesis of two new bile salt analogues, namely sodium 3 alpha,7 alpha-dihydroxy-5 beta-cholane-24-sulfonate and sodium 3 alpha,7 beta-dihydroxy-5 beta-cholane-24-sulfonate from chenodeoxycholic acid and ursodeoxycholic acid, respectively. Each common bile acid was converted into the corresponding 5 beta-cholane-3,7,24-triol by treatment with ethyl chloroformate in the presence of triethylamine followed by sodium borohydride reduction. Reaction of the cholanetriol with p-toluenesulfonyl chloride at 4 degrees C afforded the partially tosylated product, 24-p-toluenesulfoxy-5 beta-cholane-3,7-diol, which was then treated with sodium iodide to produce 24-iodo-5 beta-cholane-3,7-diol. The 24-iodide was refluxed with sodium sulfite in aqueous ethanol to give the desired sulfonate analogue of the naturally occurring bile acid, chenodeoxycholic acid or ursodeoxycholic acid.
- Published
- 1990
- Full Text
- View/download PDF
9. Reliability of J-PARC Accelerator System Over the Past Decade
- Author
-
Yoshishige Yamazaki, Naoki Hayashi, F. Naito, Katsushi Hasegawa, Michikazu Kinsho, Hidetomo Oguri, M. Yoshii, K. Yamamoto, and T. Toyama
- Subjects
Engineering ,business.industry ,J-PARC ,business ,Reliability (statistics) ,Reliability engineering - Published
- 2021
- Full Text
- View/download PDF
10. Global surveillance of trends in cancer survival 2000-14 (concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- Author
-
Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Rhea Harewood, Melissa Matz, Maja Nikšić, Audrey Bonaventure, Mikhail Valkov, Christopher J Johnson, Jacques Estève, Olufemi J Ogunbiyi, Gulnar Azevedo e Silva, Wan-Qing Chen, Sultan Eser, Gerda Engholm, Charles A Stiller, Alain Monnereau, Ryan R Woods, Otto Visser, Gek Hsiang Lim, Joanne Aitken, Hannah K Weir, Michel P Coleman, S Bouzbid, M Hamdi-Chérif, Z Zaidi, K Meguenni, D Regagba, S Bayo, T Cheick Bougadari, S S Manraj, A Fabowale, O J Ogunbiyi, D Bradshaw, N I M Somdyala, I Kumcher, F Moreno, G H Calabrano, S B Espinola, B Carballo Quintero, R Fita, M C Diumenjo, W D Laspada, S G Ibañez, C A Lima, P C F De Souza, K Del Pino, C Laporte, M P Curado, J C de Oliveira, C L A Veneziano, D B Veneziano, M R D O Latorre, L F Tanaka, M S Rebelo, M O Santos, G Azevedo e Silva, J C Galaz, M Aparicio Aravena, J Sanhueza Monsalve, D A Herrmann, S Vargas, V M Herrera, C J Uribe, L E Bravo, L S Garcia, N E Arias-Ortiz, D Morantes, D M Jurado, M C Yépez Chamorro, S Delgado, M Ramirez, Y H Galán Alvarez, P Torres, F Martínez-Reyes, L Jaramillo, R Quinto, J, M Mendoza, P Cueva, J G Yépez, B Bhakkan, J Deloumeaux, C Joachim, J Macni, R Carrillo, J Shalkow Klincovstein, R Rivera Gomez, E Poquioma, G Tortolero-Luna, D Zavala, R Alonso, E Barrios, A Eckstrand, C Nikiforuk, R R Woods, G Noonan, D Turner, E Kumar, B Zhang, F R McCrate, S Ryan, M MacIntyre, N Saint-Jacques, D E Nishri, C A McClure, K A Vriends, S Kozie, H Stuart-Panko, T Freeman, J T George, J T Brockhouse, D K O'Brien, A Holt, L Almon, S Kwong, C Morris, R Rycroft, L Mueller, C E Phillips, H Brown, B Cromartie, A G Schwartz, F Vigneau, G M Levin, B Wohler, R Bayakly, K C Ward, S L Gomez, M McKinley, R Cress, M D Green, K Miyagi, C J Johnson, L P Ruppert, C F Lynch, B Huang, T C Tucker, D Deapen, L Liu, M C Hsieh, X C Wu, M Schwenn, S T Gershman, R C Knowlton, G Alverson, G E Copeland, S Bushhouse, D B Rogers, J Jackson-Thompson, D Lemons, H J Zimmerman, M Hood, J Roberts-Johnson, J R Rees, B Riddle, K S Pawlish, A Stroup, C Key, C Wiggins, A R Kahn, M J Schymura, S Radhakrishnan, C Rao, L K Giljahn, R M Slocumb, R E Espinoza, F Khan, K G Aird, T Beran, J J Rubertone, S J Slack, L Garcia, D L Rousseau, T A Janes, S M Schwartz, S W Bolick, D M Hurley, M A Whiteside, P Miller-Gianturco, M A Williams, K Herget, C Sweeney, A T Johnson, M B Keitheri Cheteri, P Migliore Santiago, S E Blankenship, S Farley, R Borchers, R Malicki, J R Espinoza, J Grandpre, H K Weir, R Wilson, B K Edwards, A Mariotto. Y Lei, N Wang, J S Chen, Y Zhou, Y T He, G H Song, X P Gu, D Mei, H J Mu, H M Ge, T H Wu, Y Y Li, D L Zhao, F Jin, J H Zhang, F D Zhu, Q Junhua, Y L Yang, C X Jiang, W Biao, J Wang, Q L Li, H Yi, X Zhou, J Dong, W Li, F X Fu, S Z Liu, J G Chen, J Zhu, Y H Li, Y Q Lu, M Fan, S Q Huang, G P Guo, H Zhaolai, K Wei, W Q Chen, H Zeng, A V Demetriou, W K Mang, K C Ngan, A C Kataki, M Krishnatreya, P A Jayalekshmi, P Sebastian, A Nandakumar, R Malekzadeh, G Roshandel, L Keinan-Boker, B G Silverman, H Ito, H Nakagawa, M Sato, F Tobori, I Nakata, N Teramoto, M Hattori, Y Kaizaki, F Moki, H Sugiyama, M Utada, M Nishimura, K Yoshida, K Kurosawa, Y Nemoto, H Narimatsu, M Sakaguchi, S Kanemura, M Naito, R Narisawa, I Miyashiro, K Nakata, S Sato, M Yoshii, I Oki, N Fukushima, A Shibata, K Iwasa, C Ono, T Matsuda, O Nimri, K W Jung, Y J Won, E Alawadhi, A Elbasmi, A Ab Manan, F Adam, E Sanjaajmats, U Tudev, C Ochir, A M Al Khater, M M El Mistiri, G H Lim, Y Y Teo, C J Chiang, W C Lee, R Buasom, S Sangrajrang, S Kamsaard, S Wiangnon, K Daoprasert, D Pongnikorn, A Leklob, S Sangkitipaiboon, S L Geater, H Sriplung, O Ceylan, I Kög, O Dirican, T Köse, T Gurbuz, F E Karaşahin, D Turhan, U Aktaş, Y Halat, S Eser, C I Yakut, M Altinisik, Y Cavusoglu, A Türkköylü, N Üçüncü, M Hackl, A A Zborovskaya, O V Aleinikova, K Henau, L Van Eycken, Z Valerianova, M R Yordanova, M Šekerija, L Dušek, M Zvolský, G Engholm, H Storm, K Innos, M Mägi, N Malila, K Seppä, J Jégu, M Velten, E Cornet, X Troussard, A M Bouvier, A V Guizard, V Bouvier, G Launoy, P Arveux, M Maynadié, M Mounier, A S Worono, M Daoulas, M Robaszkiewicz, J Clavel, S Goujon, B Lacour, I Baldi, C Pouchieu, B Amadeo, G Coureau, A Monnereau, S Orazio, P M Preux, F Rharbaoui, E Marrer, B Trétarre, M Colonna, P Delafosse, K Ligier, S Plouvier, A Cowppli-Bony, F Molinié, S Bara, O Ganry, B Lapôtre- Ledoux, P Grosclaude, N Bossard, Z Uhry, F Bray, M Piñeros, J Estève, R Stabenow, H Wilsdorf-Köhler, A Eberle, S Luttmann, I Löhden, A L Nennecke, J Kieschke, E Sirri, K Emrich, S R Zeissig, B Holleczek, N Eisemann, A Katalinic, R A Asquez, V Kumar, E Petridou, E J Ólafsdóttir, L Tryggvadóttir, K Clough-Gorr, P M Walsh, H Sundseth, G Mazzoleni, F Vittadello, E Coviello, F Cuccaro, R Galasso, G Sampietro, A Giacomin, M Magoni, A Ardizzone, A D'Argenzio, M Castaing, G Grosso, A M Lavecchia, A Sutera Sardo, G Gola, L Gatti, P Ricci, S Ferretti, D Serraino, A Zucchetto, M V Celesia, R A Filiberti, F Pannozzo, A Melcarne, F Quarta, A G Russo, G Carrozzi, C Cirilli, L Cavalieri d'Oro, M Rognoni, M Fusco, M F Vitale, M Usala, R Cusimano, W Mazzucco, M Michiara, P Sgargi, L Boschetti, E Borciani, P Seghini, M M Maule, F Merletti, R Tumino, P Mancuso, M Vicentini, T Cassetti, R Sassatelli, F Falcini, S Giorgetti, A L Caiazzo, R Cavallo, R Cesaraccio, D R Pirino, M L Contrino, F Tisano, A C Fanetti, S Maspero, S Carone, A Mincuzzi, G Candela, T Scuderi, M A Gentilini, S Pier, S Rosso, A Barchielli, A Caldarella, F Bianconi, F Stracci, P Contiero, G Tagliabue, M Rugge, M Zorzi, S Beggiato, A Brustolin, F Berrino, G Gatta, M Sant, C Buzzoni, L Mangone, R Capocaccia, R De Angelis, R Zanetti, A Maurina, S Pildava, N Lipunova, I Vincerževskienė, D Agius, N Calleja, S Siesling, O Visser, Larønningen, B Møller, A Dyzmann-Sroka, M Trojanowski, S Góźdź, R Mężyk, T Mierzwa, L Molong, J Rachtan, S Szewczyk, J Błaszczyk, K Kępska, B Kościańska, K Tarocińska, M Zwierko, K Drosik, K M Maksimowicz, E Purwin-Porowska, E Reca, J Wójcik-Tomaszewska, A Tukiendorf, M Grądalska-Lampart, A U Radziszewska, A Gos, M Talerczyk, M Wyborska, J A Didkowska, U Wojciechowska, M Bielska-Lasota, G Forjaz de Lacerda, R A Rego, J Bastos, M A Silva, L Antunes, J Laranja Pontes, A Mayer-da-Silva, A Miranda, L M Blaga, D Coza, Russia: M Y Valkov, L Gusenkova, O Lazarevich, O Prudnikova, D M Vjushkov, A G Egorova, A E Orlov, L A Kudyakov, L V Pikalova, J Adamcik, C Safaei Diba, M Primic-Žakelj, V Zadnik, N Larrañaga, A Lopez de Munain, A A Herrera, R Redondas, R Marcos-Gragera, M L Vilardell Gil, E Molina, M J Sánchez Perez, P Franch Sureda, M Ramos Montserrat, M D Chirlaque, C Navarro, E E Ardanaz, M M Guevara, R Fernández-Delgado, R Peris-Bonet, M Carulla, J Galceran, C Alberich, M Vicente-Raneda, S Khan, D Pettersson, P Dickman, I Avelina, K Staehelin, B Camey, C Bouchardy, R Schaar, H Frick, C Herrmann, J L Bulliard, M Maspoli-Conconi, C E Kuehni, S M Redmond, A Bordoni, L Ortelli, A Chiolero, I Konzelmann, K L Matthes, S Rohrmann, Broggio, J Rashbass, D Fitzpatrick, A Gavin, D I Clark, A J Deas, D W Huws, C White, C Allemani, A Bonaventure, M P Coleman, V Di Carlo, R Harewood, M Matz, L Montel, M Nikšić, B Rachet, A D Turculeț, R Stephens, C A Stiller, E Chalker, H Phung, R Walton, H You, S Guthridge, F Johnson, J Aitken, P Gordon, K D'Onise, K Priest, B C Stokes, A Venn, H Farrugia, V Thurs eld, J Dowlin, D Currow, J Hendrix, C Lewis, Tıp Fakültesi, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Rhea Harewood, Melissa Matz, Maja Nikšić, Audrey Bonaventure, Mikhail Valkov, Christopher J Johnson, Jacques Estève, Olufemi J Ogunbiyi, Gulnar Azevedo e Silva, Wan-Qing Chen, Sultan Eser, Gerda Engholm, Charles A Stiller, Alain Monnereau, Ryan R Woods, Otto Visser, Gek Hsiang Lim, Joanne Aitken, Hannah K Weir, Michel P Coleman, S Bouzbid, M Hamdi-Chérif, Z Zaidi, K Meguenni, D Regagba, S Bayo, T Cheick Bougadari, S S Manraj, A Fabowale, O J Ogunbiyi, D Bradshaw, N I M Somdyala, I Kumcher, F Moreno, G H Calabrano, S B Espinola, B Carballo Quintero, R Fita, M C Diumenjo, W D Laspada, S G Ibañez, C A Lima, P C F De Souza, K Del Pino, C Laporte, M P Curado, J C de Oliveira, C L A Veneziano, D B Veneziano, M R D O Latorre, L F Tanaka, M S Rebelo, M O Santos, G Azevedo e Silva, J C Galaz, M Aparicio Aravena, J Sanhueza Monsalve, D A Herrmann, S Vargas, V M Herrera, C J Uribe, L E Bravo, L S Garcia, N E Arias-Ortiz, D Morantes, D M Jurado, M C Yépez Chamorro, S Delgado, M Ramirez, Y H Galán Alvarez, P Torres, F Martínez-Reyes, L Jaramillo, R Quinto, J, M Mendoza, P Cueva, J G Yépez, B Bhakkan, J Deloumeaux, C Joachim, J Macni, R Carrillo, J Shalkow Klincovstein, R Rivera Gomez, E Poquioma, G Tortolero-Luna, D Zavala, R Alonso, E Barrios, A Eckstrand, C Nikiforuk, R R Woods, G Noonan, D Turner, E Kumar, B Zhang, F R McCrate, S Ryan, M MacIntyre, N Saint-Jacques, D E Nishri, C A McClure, K A Vriends, S Kozie, H Stuart-Panko, T Freeman, J T George, J T Brockhouse, D K O'Brien, A Holt, L Almon, S Kwong, C Morris, R Rycroft, L Mueller, C E Phillips, H Brown, B Cromartie, A G Schwartz, F Vigneau, G M Levin, B Wohler, R Bayakly, K C Ward, S L Gomez, M McKinley, R Cress, M D Green, K Miyagi, C J Johnson, L P Ruppert, C F Lynch, B Huang, T C Tucker, D Deapen, L Liu, M C Hsieh, X C Wu, M Schwenn, S T Gershman, R C Knowlton, G Alverson, G E Copeland, S Bushhouse, D B Rogers, J Jackson-Thompson, D Lemons, H J Zimmerman, M Hood, J Roberts-Johnson, J R Rees, B Riddle, K S Pawlish, A Stroup, C Key, C Wiggins, A R Kahn, M J Schymura, S Radhakrishnan, C Rao, L K Giljahn, R M Slocumb, R E Espinoza, F Khan, K G Aird, T Beran, J J Rubertone, S J Slack, L Garcia, D L Rousseau, T A Janes, S M Schwartz, S W Bolick, D M Hurley, M A Whiteside, P Miller-Gianturco, M A Williams, K Herget, C Sweeney, A T Johnson, M B Keitheri Cheteri, P Migliore Santiago, S E Blankenship, S Farley, R Borchers, R Malicki, J R Espinoza, J Grandpre, H K Weir, R Wilson, B K Edwards, A Mariotto. Y Lei, N Wang, J S Chen, Y Zhou, Y T He, G H Song, X P Gu, D Mei, H J Mu, H M Ge, T H Wu, Y Y Li, D L Zhao, F Jin, J H Zhang, F D Zhu, Q Junhua, Y L Yang, C X Jiang, W Biao, J Wang, Q L Li, H Yi, X Zhou, J Dong, W Li, F X Fu, S Z Liu, J G Chen, J Zhu, Y H Li, Y Q Lu, M Fan, S Q Huang, G P Guo, H Zhaolai, K Wei, W Q Chen, H Zeng, A V Demetriou, W K Mang, K C Ngan, A C Kataki, M Krishnatreya, P A Jayalekshmi, P Sebastian, A Nandakumar, R Malekzadeh, G Roshandel, L Keinan-Boker, B G Silverman, H Ito, H Nakagawa, M Sato, F Tobori, I Nakata, N Teramoto, M Hattori, Y Kaizaki, F Moki, H Sugiyama, M Utada, M Nishimura, K Yoshida, K Kurosawa, Y Nemoto, H Narimatsu, M Sakaguchi, S Kanemura, M Naito, R Narisawa, I Miyashiro, K Nakata, S Sato, M Yoshii, I Oki, N Fukushima, A Shibata, K Iwasa, C Ono, T Matsuda, O Nimri, K W Jung, Y J Won, E Alawadhi, A Elbasmi, A Ab Manan, F Adam, E Sanjaajmats, U Tudev, C Ochir, A M Al Khater, M M El Mistiri, G H Lim, Y Y Teo, C J Chiang, W C Lee, R Buasom, S Sangrajrang, S Kamsaard, S Wiangnon, K Daoprasert, D Pongnikorn, A Leklob, S Sangkitipaiboon, S L Geater, H Sriplung, O Ceylan, I Kög, O Dirican, T Köse, T Gurbuz, F E Karaşahin, D Turhan, U Aktaş, Y Halat, S Eser, C I Yakut, M Altinisik, Y Cavusoglu, A Türkköylü, N Üçüncü, M Hackl, A A Zborovskaya, O V Aleinikova, K Henau, L Van Eycken, Z Valerianova, M R Yordanova, M Šekerija, L Dušek, M Zvolský, G Engholm, H Storm, K Innos, M Mägi, N Malila, K Seppä, J Jégu, M Velten, E Cornet, X Troussard, A M Bouvier, A V Guizard, V Bouvier, G Launoy, P Arveux, M Maynadié, M Mounier, A S Worono, M Daoulas, M Robaszkiewicz, J Clavel, S Goujon, B Lacour, I Baldi, C Pouchieu, B Amadeo, G Coureau, A Monnereau, S Orazio, P M Preux, F Rharbaoui, E Marrer, B Trétarre, M Colonna, P Delafosse, K Ligier, S Plouvier, A Cowppli-Bony, F Molinié, S Bara, O Ganry, B Lapôtre- Ledoux, P Grosclaude, N Bossard, Z Uhry, F Bray, M Piñeros, J Estève, R Stabenow, H Wilsdorf-Köhler, A Eberle, S Luttmann, I Löhden, A L Nennecke, J Kieschke, E Sirri, K Emrich, S R Zeissig, B Holleczek, N Eisemann, A Katalinic, R A Asquez, V Kumar, E Petridou, E J Ólafsdóttir, L Tryggvadóttir, K Clough-Gorr, P M Walsh, H Sundseth, G Mazzoleni, F Vittadello, E Coviello, F Cuccaro, R Galasso, G Sampietro, A Giacomin, M Magoni, A Ardizzone, A D'Argenzio, M Castaing, G Grosso, A M Lavecchia, A Sutera Sardo, G Gola, L Gatti, P Ricci, S Ferretti, D Serraino, A Zucchetto, M V Celesia, R A Filiberti, F Pannozzo, A Melcarne, F Quarta, A G Russo, G Carrozzi, C Cirilli, L Cavalieri d'Oro, M Rognoni, M Fusco, M F Vitale, M Usala, R Cusimano, W Mazzucco, M Michiara, P Sgargi, L Boschetti, E Borciani, P Seghini, M M Maule, F Merletti, R Tumino, P Mancuso, M Vicentini, T Cassetti, R Sassatelli, F Falcini, S Giorgetti, A L Caiazzo, R Cavallo, R Cesaraccio, D R Pirino, M L Contrino, F Tisano, A C Fanetti, S Maspero, S Carone, A Mincuzzi, G Candela, T Scuderi, M A Gentilini, S Pier, S Rosso, A Barchielli, A Caldarella, F Bianconi, F Stracci, P Contiero, G Tagliabue, M Rugge, M Zorzi, S Beggiato, A Brustolin, F Berrino, G Gatta, M Sant, C Buzzoni, L Mangone, R Capocaccia, R De Angelis, R Zanetti, A Maurina, S Pildava, N Lipunova, I Vincerževskienė, D Agius, N Calleja, S Siesling, O Visser, Larønningen, B Møller, A Dyzmann-Sroka, M Trojanowski, S Góźdź, R Mężyk, T Mierzwa, L Molong, J Rachtan, S Szewczyk, J Błaszczyk, K Kępska, B Kościańska, K Tarocińska, M Zwierko, K Drosik, K M Maksimowicz, E Purwin-Porowska, E Reca, J Wójcik-Tomaszewska, A Tukiendorf, M Grądalska-Lampart, A U Radziszewska, A Gos, M Talerczyk, M Wyborska, J A Didkowska, U Wojciechowska, M Bielska-Lasota, G Forjaz de Lacerda, R A Rego, J Bastos, M A Silva, L Antunes, J Laranja Pontes, A Mayer-da-Silva, A Miranda, L M Blaga, D Coza, Russia: M Y Valkov, L Gusenkova, O Lazarevich, O Prudnikova, D M Vjushkov, A G Egorova, A E Orlov, L A Kudyakov, L V Pikalova, J Adamcik, C Safaei Diba, M Primic-Žakelj, V Zadnik, N Larrañaga, A Lopez de Munain, A A Herrera, R Redondas, R Marcos-Gragera, M L Vilardell Gil, E Molina, M J Sánchez Perez, P Franch Sureda, M Ramos Montserrat, M D Chirlaque, C Navarro, E E Ardanaz, M M Guevara, R Fernández-Delgado, R Peris-Bonet, M Carulla, J Galceran, C Alberich, M Vicente-Raneda, S Khan, D Pettersson, P Dickman, I Avelina, K Staehelin, B Camey, C Bouchardy, R Schaar, H Frick, C Herrmann, J L Bulliard, M Maspoli-Conconi, C E Kuehni, S M Redmond, A Bordoni, L Ortelli, A Chiolero, I Konzelmann, K L Matthes, S Rohrmann, Broggio, J Rashbass, D Fitzpatrick, A Gavin, D I Clark, A J Deas, D W Huws, C White, C Allemani, A Bonaventure, M P Coleman, V Di Carlo, R Harewood, M Matz, L Montel, M Nikšić, B Rachet, A D Turculeț, R Stephens, C A Stiller, E Chalker, H Phung, R Walton, H You, S Guthridge, F Johnson, J Aitken, P Gordon, K D'Onise, K Priest, B C Stokes, A Venn, H Farrugia, V Thurs eld, J Dowlin, D Currow, J Hendrix, C Lewis
- Subjects
0301 basic medicine ,Universal Health Coverage ,population-based registries ,Relative Survival ,Settore MED/42 - Igiene Generale E Applicata ,Cancer -- Treatment ,Humans ,Neoplasms ,Population Surveillance ,Registries ,Survival Rate ,Medicine (all) ,0302 clinical medicine ,cancer survival ,education.field_of_study ,Relative survival ,EPICENE ,General Medicine ,3. Good health ,trend ,030220 oncology & carcinogenesis ,Public-Health ,cancer surveillance ,Liver cancer ,survival ,cancer registry ,CONCORD-3 ,Cure ,Childhood-Cancer ,medicine.medical_specialty ,population-based cancer registries ,Womens Cancers ,Population ,Medicine (all),cancer survival, population-based cancer registries ,Socio-culturale ,United-States ,Article ,03 medical and health sciences ,Breast cancer ,Cancer epidemiology ,medicine ,Nordic-Countries ,Cancer -- Mortality ,education ,Survival rate ,Cancer prevention ,Alternative Approach ,business.industry ,Public health ,Cancer ,Cancer -- Patients -- Long-term care ,medicine.disease ,030104 developmental biology ,High-Income Countries ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,Demography - Abstract
Eser, Sultan (Balikesir Author), Background In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. Methods CONCORD-3 includes individual records for 37.5 million patients diagnosed with cancer during the 15-year period 2000-14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by the registry concerned. We estimated 5-year net survival. Estimates were age-standardised with the International Cancer Survival Standard weights.Findings For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden. For many cancers, Denmark is closing the survival gap with the other Nordic countries. Survival trends are generally increasing, even for some of the more lethal cancers: in some countries, survival has increased by up to 5% for cancers of the liver, pancreas, and lung. For women diagnosed during 2010-14, 5-year survival for breast cancer is now 89.5% in Australia and 90.2% in the USA, but international differences remain very wide, with levels as low as 66.1% in India. For gastrointestinal cancers, the highest levels of 5-year survival are seen in southeast Asia: in South Korea for cancers of the stomach (68.9%), colon (71.8%), and rectum (71.1%); in Japan for oesophageal cancer (36.0%); and in Taiwan for liver cancer (27.9%). By contrast, in the same world region, survival is generally lower than elsewhere for melanoma of the skin (59.9% in South Korea, 52.1% in Taiwan, and 49.6% in China), and for both lymphoid malignancies (52.5%, 50.5%, and 38.3%) and myeloid malignancies (45.9%, 33.4%, and 24.8%). For children diagnosed during 2010-14, 5-year survival for acute lymphoblastic leukaemia ranged from 49.8% in Ecuador to 95.2% in Finland. 5-year survival from brain tumours in children is higher than for adults but the global range is very wide (from 28.9% in Brazil to nearly 80% in Sweden and Denmark). Interpretation The CONCORD programme enables timely comparisons of the overall effectiveness of health systems in providing care for 18 cancers that collectively represent 75% of all cancers diagnosed worldwide every year. It contributes to the evidence base for global policy on cancer control. Since 2017, the Organisation for Economic Co-operation and Development has used findings from the CONCORD programme as the official benchmark of cancer survival, among their indicators of the quality of health care in 48 countries worldwide. Governments must recognise population-based cancer registries as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems for all patients diagnosed with cancer., American Cancer Society Centers for Disease Control and Prevention Swiss Re Swiss Cancer Research foundation Swiss Cancer League Institut National du Cancer La Ligue Contre le Cancer Rossy Family Foundation US National Cancer Institute Susan G Komen Foundation
- Published
- 2018
- Full Text
- View/download PDF
11. J-PARC-HI Collaboration
- Author
-
J.K. Ahn, Y. Akamatsu, M. Asakawa, S. Ashikaga, O. Busch, E. Chishiro, M. Chiu, T. Chujo, P. Cirkovic, T. Csörgő, G. David, D. Devetak, M. Djordjevic, S. Esumi, H. Fujii, K. Fukushima, P. Garg, T. Gunji, T. Hachiya, H. Hamagaki, H. Harada, M. Harada, S. Hasegawa, Y. Hashimoto, T. Hatsuda, N. Hayashi, K. Hirano, T. Hirano, B.S. Hong, H. Hotchi, S.H. Hwang, Y. Ichikawa, T. Ichisawa, K. Imai, M. Inaba, K. Ishii, K. Itakura, T. Ito, J. Kamiya, M. Kaneta, H. Kato, S. Kato, N. Kikuzawa, B.C. Kim, E.J. Kim, T. Kimura, M. Kinsho, R. Kitamura, M. Kitazawa, Y. Kondo, A. Kovalenko, H. Kuboki, Y. Kurimoto, Y. Liu, X. Luo, T. Maruyama, S. Meigo, Y. Miake, A. Miura, T. Miyao, J. Milosevic, D. Mishra, T. Morishita, K. Morita, Y. Morita, K. Moriya, K. Murase, R. Muto, L. Nadjdjerdj, S. Nagamiya, A. Nakamura, T. Nakamura, T. Nakanoya, Y. Nara, M. Naruki, K. Niki, K. Nishio, C. Nonaka, T. Nonaka, M. Ogino, H. Oguri, C. Ohmori, A. Ohnishi, M. Oka, A. Okabe, M. Okamura, K. Oyama, K. Ozawa, P.K. Saha, T.R. Saito, A. Sakaguchi, T. Sakaguchi, S. Sakai, H. Sako, K. Sato, S. Sato, Y. Sato, S. Sawada, T. Shibata, K. Shigaki, S. Shimansky, T. Shimokawa, M. Shimomura, K. Shindo, S. Shinozaki, M. Shirakata, Y. Shobuda, M. Stojanovic, K. Suganuma, H. Sugimura, Y. Sugiyama, H. Takahashi, T. Takayanagi, Y. Takeuchi, F. Tamura, H. Tamura, J. Tamura, K.H. Tanaka, Y. Tanaka, N. Tani, K. Tanida, M. Tomisawa, T. Toyama, Y. Watanabe, N. Xu, K. Yamamoto, M. Yamamoto, S. Yokkaichi, I.K. Yoo, M. Yoshii, and M. Yoshimoto
- Subjects
Nuclear and High Energy Physics - Published
- 2021
- Full Text
- View/download PDF
12. Studies on Coherent Multi-Bunch Tune Shifts with Different Bunch Spacing at the J-PARC Main Ring
- Author
-
T. Shimogawa, S. Igarashi, Y. Sugiyama, T. Toyama, Y. Sato, M. Yoshii, and A. Kobayashi
- Subjects
Physics ,History ,Proton ,MC5: Beam Dynamics and EM Fields ,Physics::Accelerator Physics ,J-PARC ,Atomic physics ,Ring (chemistry) ,Space charge ,Electrical impedance ,Computer Science Applications ,Education ,Accelerator Physics - Abstract
At a high-power proton synchrotron, betatron tune shifts induced by space charge effects cause beam loss which limits the beam intensity. To achieve further high beam intensity at the main ring of the Japan Proton Accelerator Research Complex, precise control of the tune shift is indispensable. When carrying out multi-bunch measurements, we observed that the dependence of the tune shift intensity on the number of bunches follow opposite slope trends for the horizontal and vertical directions. The influence of the bunch spacing was also observed. We report on a simplified tune shift model reconstruction for understanding the origin of these phenomena and present a correction of the tune shifts for reducing beam loss up to 30 %., Proceedings of the 10th Int. Particle Accelerator Conf., IPAC2019, Melbourne, Australia
- Published
- 2019
- Full Text
- View/download PDF
13. Evaluation of unexpected positive results from a commercial ELISA for antibodies to PRRSV
- Author
-
T. Suzuki, Hiroshi Tsunemitsu, T. Yamagishi, M. Takagi, M. Yoshii, T. Okinaga, and A. Miyazaki
- Subjects
General Veterinary ,biology ,Swine ,Porcine Reproductive and Respiratory Syndrome ,Enzyme-Linked Immunosorbent Assay ,General Medicine ,Antibodies, Viral ,Porcine reproductive and respiratory syndrome virus ,biology.organism_classification ,Serum samples ,Sensitivity and Specificity ,Virology ,mental disorders ,Immunology ,biology.protein ,Animals ,False Positive Reactions ,Porcine respiratory and reproductive syndrome virus ,Antibody ,Fluorescent Antibody Technique, Indirect ,Direct fluorescent antibody ,psychological phenomena and processes - Abstract
Unexpected positive results from the widely used IDEXX ELISA for the detection of antibodies to porcine reproductive and respiratory syndrome virus (PRRSV) may confound investigations of the disease. Supplementing the ELISA with blocking agents and the use of IgG purified from serum samples had no effect on the unexpected positive results, suggesting that they were due to an antibody-antigen reaction. Simple competitive and blocking ELISAs were developed by modifying the IDEXX ELISA, and they and an indirect fluorescent antibody test (IFAT) were used to examine PRRSV antibodies in 33 antibody-negative, 88 antibody-positive and 73 unexpectedly positive sera. All the unexpectedly positive sera were negative by IFAT, and 89.0 per cent were negative by both the competitive and blocking ELISAs. The competitive ELISA (97.7 per cent) and the blocking ELISA (96.5 per cent) detected more positive sera than the IFAT (90.9 per cent). These results show that both ELISAs are capable of distinguishing positive and unexpectedly positive sera, and suggest that most of the unexpected positive signals are false-positives.
- Published
- 2009
- Full Text
- View/download PDF
14. Investigation Into the Release Behavior and Releasability Evaluation of the Encapsulation of Semiconductor Packages
- Author
-
N. Suzuki and M. Yoshii
- Subjects
Materials science ,Transfer molding ,business.industry ,technology, industry, and agriculture ,Electronic packaging ,Semiconductor package ,Semiconductor device ,Surface finish ,medicine.disease_cause ,Industrial and Manufacturing Engineering ,Semiconductor ,Mold ,medicine ,Surface roughness ,Electrical and Electronic Engineering ,Composite material ,business - Abstract
One disincentive to the encapsulation of semiconductor devices using transfer molding is the resulting deterioration in releasability. This is because deterioration in releasability causes the chip to crack and external appearance defects to be transcribed from the mold stain. In this study, the authors have measured the in situ release force using an actual semiconductor package (LQFP2020), and have investigated the release behavior by numerically simulating the release process. The release force was found to be about 5 to 8 N, and the release time was 30 ms or less after continuous molding of 300 shots. The relationship between various release factors and the release force was also investigated. With regard to the surface roughness of the mold cavity, the release force of a ldquosatin-finished surfacerdquo was about half of that of a ldquomirror surface.rdquo In addition, the release force was slightly reduced by reducing the cure time and the release speed.
- Published
- 2007
- Full Text
- View/download PDF
15. Nonsuppurative Encephalitis in Piglets after Experimental Inoculation of Japanese Encephalitis Flavivirus Isolated from Pigs
- Author
-
M. Yoshii, K. Nakamura, Y. Kaku, and M. Yamada
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Neuronophagia ,Swine ,040301 veterinary sciences ,viruses ,0403 veterinary science ,03 medical and health sciences ,medicine ,Animals ,Antigens ,Encephalitis Virus, Japanese ,Swine Diseases ,General Veterinary ,biology ,Cerebrum ,Brain ,04 agricultural and veterinary sciences ,Japanese encephalitis ,biology.organism_classification ,medicine.disease ,Spinal cord ,Immunohistochemistry ,Virology ,Pons ,Flavivirus ,030104 developmental biology ,medicine.anatomical_structure ,nervous system ,Medulla oblongata ,Encephalitis - Abstract
Nonsuppurative encephalitis was experimentally induced in 3-week-old piglets by a single intravenous inoculation of either of two strains (IB 2001 or AS-6) of Japanese encephalitis flavivirus (JEV) isolated from field pigs. The lesions, which consisted of neuronal necrosis, neuronophagia, glial nodules, and perivascular cuffing, were distributed in the cerebrum, midbrain, pons, medulla oblongata, and cerebellum, particularly in the gray matter of the frontal and temporal lobes and thalamus. The gray matter of the spinal cord of piglets that were given the AS-6 strain also was affected. JEV antigen was immunohistochemically detected in the cytoplasm of the nerve cells in the cortex of the frontal and temporal lobes and in the gray matter of the thalamus and midbrain. Two JEV strains isolated from field pigs exhibited neurovirulence, inducing nonsuppurative encephalitis in piglets.
- Published
- 2004
- Full Text
- View/download PDF
16. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL
- Author
-
Akihiro Murata, Akiomi Miyata, Haruhisa Noda, K. Watanabe, Manami Kinjo, Kikuo Nutahara, Takatsugu Okegawa, Moriaki Kato, M. Yoshii, and Eiji Higashihara
- Subjects
medicine.medical_specialty ,Pathology ,medicine.diagnostic_test ,Receiver operating characteristic ,business.industry ,Urology ,Rectum ,Rectal examination ,medicine.disease ,Prostate cancer ,Prostate-specific antigen ,medicine.anatomical_structure ,Prostate ,Immunoassay ,medicine ,Transrectal ultrasonography ,business - Abstract
Objective To compare the ratio of free prostate specific antigen (fPSA), total PSA (tPSA) and complexed PSA (cPSA, measured using a novel immunoassay) with other variables used to detect prostate cancer in patients with intermediate serum PSA levels of 4.1–10.0 ng/mL. Patients and methods From July 1997 to August 1998, 140 consecutive patients were assessed; all had intermediate serum PSA levels and/or abnormal findings on a digital rectal examination. All patients underwent transrectal ultrasonography (TRUS)-guided biopsy, and the prostate and transition zone volumes were determined by TRUS. Free and tPSA were measured using the Tandem-R assay (Hybritech Corp., San Diego, CA). PSA complexed with α1-antichymotrypsin (cPSA) was measured using an appropriate assay. The ability of cPSA, free-to-total PSA ratio (f/tPSA), free-to-complexed PSA ratio (f/cPSA), tPSA density of the whole prostate (PSAD), of the transition zone (tPSATZ), and cPSA density of the whole prostate (cPSAD) and of the transition zone (cPSATZ) to improve the power of PSA in detecting prostate cancer was evaluated using receiver operating characteristic (ROC) curves. Results Of the 140 patients, 126 had histologically confirmed benign disease and 14 had prostate cancer. The cPSA alone had better specificity for detecting prostate cancer than had tPSA alone but the difference was not significant. The area under the ROC curve for f/cPSA was larger than those for all other variables. With a 93% sensitivity for detecting prostate cancer, a f/cPSA threshold of 25% would result in fewer unnecessary biopsies (40% f/cPSA specificity) than with all other PSA variables. The difference in the resolution was significant between f/cPSA and tPSA, cPSA, tPSAD and tPSATZ, but not with f/tPSA, cPSAD or cPSATZ. In patients with a prostate volume of
- Published
- 2001
- Full Text
- View/download PDF
17. Production of radioactive endovascular stents by implantation of 133Xe ions
- Author
-
Mitsuo Koizumi, Eiichi Okamoto, Ryozo Nagai, N. S. Ishioka, Satoshi Watanabe, A. Hasegawa, T. Kojima, K. Aoyagi, Akihiko Osa, A. Miyajima, M. Yoshii, and Toshiaki Sekine
- Subjects
medicine.medical_specialty ,Materials science ,medicine.medical_treatment ,Radiation Dosage ,Ionizing radiation ,Ion ,Implants, Experimental ,Coronary stent ,medicine ,Animals ,Stent implantation ,Aorta, Abdominal ,cardiovascular diseases ,Angioplasty, Balloon, Coronary ,Neointimal hyperplasia ,Radiation ,business.industry ,Stent ,equipment and supplies ,medicine.disease ,surgical procedures, operative ,Ion implantation ,Isotope Labeling ,Stents ,Rabbits ,Radiology ,Thickening ,Tunica Intima ,Nuclear medicine ,business ,Cell Division ,Xenon Radioisotopes - Abstract
A coronary stent was made radioactive by implantation of 133Xe ions for the purpose of suppressing the re-narrowing of the part of blood vessel in which the stent is implanted. Electrons of relatively low energies emitted in the decay of 133Xe may give an antiproliferative effect of ionizing radiation to the intimal cells within a limited range of 1 mm. A 133Xe+ beam accelerated at 40 or 60 keV was directed to several stainless steel stents mounted on a target-holder table that could revolve and move up and down to distribute the 133Xe+ ions within a stent as well as among the stents. The radioactive stents produced contained up to 100 kBq of 133Xe and were implanted into the abdominal aortas of rabbits. Neointimal thickening was analyzed by histomorphometry for samples taken 4 weeks after stent implantation. The results indicate that the radioactive stents have a potential to suppress neointimal hyperplasia in rabbits.
- Published
- 1999
- Full Text
- View/download PDF
18. 15 alpha-hydroxylation of a bile acid analogue, sodium 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate in the hamster
- Author
-
Nariman Ayyad, E H Mosbach, T Hoshita, M Yoshii, B I Cohen, C D Schteingart, A. Ohshima, K Ohtani, T Mikami, and K Kihira
- Subjects
Lithocholic acid ,Chromatography ,Bile acid ,medicine.drug_class ,Metabolite ,Hamster ,Cell Biology ,Metabolism ,QD415-436 ,Biochemistry ,Hydroxylation ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Oral administration ,medicine ,Enterohepatic circulation - Abstract
The metabolism of 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate (bishomoCDC-sul), the sulfonate analogue of bishomochenodeoxycholic acid, and its effect on biliary bile acid composition were studied during chronic administration in the hamster. After oral administration of radiolabeled bishomoCDC-sul, more than 80% of the radioactivity was excreted into the feces within 7 days, both as the unchanged sulfonate (38.5%) and two more polar metabolites (50.0% and 11.5%). The half time of the fecal excretion was 1.6 days. In gallbladder bile, the unchanged sulfonate and its major metabolite accounted for 19.1% and 19.8% of total bile acids, respectively. In another experiment, hamsters were fed bishomoCDC-sul with antibiotics to evaluate the site of biotransformation. Even when the number of intestinal microorganisms was greatly reduced, the same three metabolites were found in the feces: bishomoCDC-sul (44.0%) and the two polar metabolites (30.8% and 25.1%). The major metabolite was isolated from feces of the hamsters fed bishomoCDC-sul without antibiotics. Its chemical structure was identified by mass spectrometry and nuclear magnetic resonance spectroscopy as the 15 alpha-hydroxylated derivative, namely sodium 3 alpha,7 alpha,15 alpha-trihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate. These results indicate that after oral administration, the sulfonate analogue of bishomochenodeoxycholic acid underwent enterohepatic circulation like a natural bile acid and was transformed, in part, into the 15 alpha-hydroxylated derivative and another more polar metabolite in the liver of hamsters. There was no evidence that bishomoCDC-sul was dehydroxylated to a lithocholic acid analogue during enterohepatic cycling.
- Published
- 1996
19. Hyperparathyroidism — Comparison of Flash Imaging with Spin ECHO MR Imaging
- Author
-
Junpei Ikezoe, Y. Noguchi, Takenori Kozuka, T. Koide, M. Yoshii, and Shodayu Takashima
- Subjects
Hyperparathyroidism ,genetic structures ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,General Medicine ,medicine.disease ,Signal ,Mr imaging ,Flash (photography) ,Nuclear magnetic resonance ,Flip angle ,medicine ,Spin echo ,Radiology, Nuclear Medicine and imaging ,Mr images ,Nuclear medicine ,business - Abstract
MR images of the neck were prospectively studied in 19 patients with hyperparathyroidism. Fast low angle shot (FLASH) sequence was performed in addition to T1- and T2-weighted spin echo (SE) sequences. FLASH images were obtained with 320/12/20° (TR/TE/flip angle) using presaturation technique. TE of 12 ms was chosen to eliminate high signal of fat tissue. In the evaluation of detectability, a combination of T1-weighted SE and FLASH images (T1WI + FLASH) was compared with a combination of T1- and T2-weighted SE images (T1WI + T2WI). MR imaging correctly depicted 20 of 30 abnormal glands on both T1WI + FLASH and T1WI + T2WI. FLASH imaging effectively eliminated high signal of fat tissue. Nineteen abnormal glands demonstrated higher signal than surrounding tissues on FLASH images, whereas 12 glands were high-intense on T2-weighted SE images. We conclude that FLASH imaging provides improved tissue contrast and anatomic delineation and, thus, may replace T2-weighted SE imaging in the neck.
- Published
- 1993
- Full Text
- View/download PDF
20. Inhibitory effects of psychotomimetic σ ligands on nicotine-induced K+ flux from differentiated PC12 cells
- Author
-
N. Sagi, Toshifumi Yamamoto, Hideko Yamamoto, M. Yoshii, Takashi Moroji, M. Okuwa, and Y. Goji
- Subjects
Nicotine ,Potassium Channels ,Chemistry ,Stereochemistry ,General Neuroscience ,Sigma receptor ,Antagonist ,chemistry.chemical_element ,Pharmacology ,Calcium ,Psychotomimetic ,Ligand (biochemistry) ,PC12 Cells ,Rats ,Dizocilpine ,Nicotinic agonist ,Receptors, Opioid, delta ,Hallucinogens ,Potassium ,medicine ,Animals ,Receptors, Cholinergic ,Microelectrodes ,Phencyclidine ,medicine.drug - Abstract
In NGF-treated PC12 cells, nicotine-induced K+ release was measured with a K(+)-sensitive microelectrode. The K+ outflow via nicotinic ACh receptor cation channels was inhibited by various psychotomimetic sigma ligands in the sequence of PCP, dextromethorphan >> DTG, MK 801, (+)SKF10047 >> (+)3-PPP. The K+ release was not affected by the neuroleptic sigma ligand haloperidol nor by the calcium antagonist nifedipine. The results suggest that psychotomimetic sigma ligands inhibit nicotine-stimulated K+ flux by interacting with nicotinic, rather than via sigma 2 receptors.
- Published
- 1992
- Full Text
- View/download PDF
21. Beam commissioning of the 3-GeV rapid cycling synchrotron of the Japan Proton Accelerator Research Complex
- Author
-
H. Hotchi, M. Kinsho, K. Hasegawa, N. Hayashi, Y. Hikichi, S. Hiroki, J. Kamiya, K. Kanazawa, M. Kawase, F. Noda, M. Nomura, N. Ogiwara, R. Saeki, P. K. Saha, A. Schnase, Y. Shobuda, T. Shimada, K. Suganuma, H. Suzuki, H. Takahashi, T. Takayanagi, O. Takeda, F. Tamura, N. Tani, T. Togashi, T. Ueno, M. Watanabe, Y. Watanabe, K. Yamamoto, M. Yamamoto, Y. Yamazaki, H. Yoshikawa, M. Yoshimoto, A. Ando, H. Harada, Y. Irie, C. Ohmori, K. Satou, and M. Yoshii
- Subjects
Physics ,Nuclear and High Energy Physics ,medicine.medical_specialty ,Physics and Astronomy (miscellaneous) ,Nuclear engineering ,Beam commissioning ,Particle accelerator ,Surfaces and Interfaces ,Beam optics ,Synchrotron ,law.invention ,Acceleration ,Rapid cycling ,law ,medicine ,lcsh:QC770-798 ,Medical physics ,lcsh:Nuclear and particle physics. Atomic energy. Radioactivity ,Beam (structure) - Abstract
The 3-GeV rapid cycling synchrotron (RCS) of the Japan Proton Accelerator Research Complex (J-PARC) was commissioned in October 2007, and successfully accomplished 3 GeV acceleration on October 31. Six run cycles through February 2008 were dedicated to commissioning the RCS, for which the initial machine parameter tuning and various underlying beam studies were completed. Then since May 2008 the RCS beam has been delivered to the downstream facilities for their beam commissioning. In this paper we describe beam tuning and study results following our beam commissioning scenario and a beam performance and operational experience obtained in the first commissioning phase through June 2008.
- Published
- 2009
22. EPILEPTOGENESIS | Specific Gene Expression Before and After Seizure in Epileptic EL Mice
- Author
-
Suzuki Jiro, M. Yoshii, and Y.L. Murashima
- Subjects
Epilepsy ,Nerve growth factor ,Seizure threshold ,Neurotrophic factors ,medicine ,Context (language use) ,Ictal ,Interleukin-1 receptor ,Biology ,medicine.disease ,Neuroscience ,Epileptogenesis - Abstract
Ictogenesis and epileptogenesis during development are key phenomena in the establishment of epilepsy. In exploring these processes, we will clarify not only the mechanisms of abnormalities for the neuronal network, but also the physiology of higher brain functions such as learning and memory. Since epilepsy is defined as the repeated synchronous hyperactivity of cortical neurons, it is also important to view epileptic phenomena according to ‘states’ – i.e., transition from the preictal to the ictal state and from the interictal to the ictal state. In this context, when we discuss ‘repeated’ hyperactivity, we generally refer to transitions from the interictal to the ictal state, and when we investigate ‘the first synchronous’ discharge, we generally refer to transition from the preictal to the ictal state. During epileptogenesis, a large number of genes are expressed, and this expression is dependent on the development state of the animal as well as the epileptic ‘state.’ Among the genes that are highly expressed are those responsible for free-radical production and synaptic reorganization, inducible nitric oxide synthetase (i-NOS), constitutive neural NOS (n-NOS), epitherial NOS (e-NOS), apoptosis regulation (Bcl-2, Bcl-XL, Bax), neurotrophic factors (brain-derived nerve growth factor (BDNF), fibloblast growing factor-2 (FGF-2), neurotrophin-3 (NT-3)), cell-cycle reentry (cycalin A, B, D, E, cyclin-dependent kinase-1,-2,-4 (CDK-1, -2, -4)), and inflammatory signal transduction (IL-1a, IL-1b, tumor necrotizing factor-a (TNF-a), interleukin 1 receptor (IL-1r), interleukin 1 receptor antagonist (IL-1ra)). The EL mouse is an animal model of secondary generalized seizure. Seizure threshold in this animal depends on its developmental state and its seizure history. Thus, the EL mouse is a particularly useful animal model to investigate the role or significance of seizure-related expression of different genes.
- Published
- 2009
- Full Text
- View/download PDF
23. Pathological changes in pigs experimentally infected with porcine teschovirus
- Author
-
H. Tsunemitsu, A. Miyazaki, M. Yamada, Y. Kaku, R. Kozakura, K. Nakamura, Y. Yamamoto, M. Yoshii, and Minoru Narita
- Subjects
Nervous system ,Pathology ,medicine.medical_specialty ,Neuronophagia ,Teschovirus ,Swine ,Encephalomyelitis ,Central nervous system ,Administration, Oral ,Pathology and Forensic Medicine ,Ganglia, Spinal ,Pons ,Medicine ,Animals ,Administration, Intranasal ,Swine Diseases ,Picornaviridae Infections ,General Veterinary ,biology ,business.industry ,Anatomy ,medicine.disease ,biology.organism_classification ,Spinal cord ,Immunohistochemistry ,Ganglion ,medicine.anatomical_structure ,Gliosis ,Injections, Intravenous ,medicine.symptom ,business - Abstract
Nonsuppurative encephalomyelitis with neurological signs expressed as flaccid paralysis of the hindlimbs was experimentally induced in three-week-old piglets by a single intravenous injection of the Toyama 2002 strain of porcine teschovirus (PTV) isolated from field pigs in Japan. Lesions characterized by perivascular cuffing of mononuclear cells, focal gliosis, neuronal necrosis and neuronophagia were observed, mainly in the ventral horn of the spinal cord. Nonsuppurative ganglionitis of the spinal ganglion and neuritis of the spinal root were also detected. PTV antigens were detected immunohistochemically and the distribution of these antigens corresponded closely with the distribution of brain lesions. PTV antigens were observed in the ganglion cells before the appearance of the inflammatory changes 3 days post-inoculation (dpi) and were present in the dorsal root and spinal cord on 9 dpi. No lesions of the central nervous system were induced in pigs by oral or intranasal inoculation of this strain of PTV.
- Published
- 2008
24. Brain lesions induced by experimental intranasal infection of Japanese encephalitis virus in piglets
- Author
-
Y. Kaku, K. Nakamura, M. Yoshii, Minoru Narita, and M. Yamada
- Subjects
Olfactory system ,Pathology ,medicine.medical_specialty ,Swine ,viruses ,Biology ,Virus ,Pathology and Forensic Medicine ,Cortex (anatomy) ,medicine ,Animals ,Encephalitis, Japanese ,Encephalitis Virus, Japanese ,Swine Diseases ,General Veterinary ,Pyramidal Cells ,Brain ,Olfactory Pathways ,Japanese encephalitis ,medicine.disease ,Granule cell ,Olfactory bulb ,Specific Pathogen-Free Organisms ,Disease Models, Animal ,medicine.anatomical_structure ,Neuroglia ,Encephalitis ,Olfactory tract - Abstract
Non-suppurative encephalitis was experimentally induced in three-week-old piglets by a single intranasal inoculation of Japanese encephalitis virus (JEV) isolated from field pigs. The lesions consisted of glial cell aggregates and perivascular cuffing throughout the olfactory tract and pyriform cortex. JEV antigens were detected in the cytoplasm and neuronal processes of small nerve cells in the granule cell layer of the olfactory bulb, in the neuronal processes of the olfactory tract and in the cytoplasm of neurons in the pyriform cortex. The distribution of the antigens corresponded closely with the distribution of brain lesions. These findings suggest that JEV may enter the brain by the olfactory pathway in addition to via haematogenous spread in piglets.
- Published
- 2008
25. Spatial Selectivity of Pattern Electroretinogram Components
- Author
-
M. Yoshii and E. Dodt
- Subjects
Adult ,Light ,media_common.quotation_subject ,Luminance ,Contrast Sensitivity ,Arc (geometry) ,Cellular and Molecular Neuroscience ,Optics ,Electroretinography ,medicine ,Humans ,Contrast (vision) ,media_common ,Physics ,medicine.diagnostic_test ,business.industry ,General Medicine ,Sensory Systems ,Ophthalmology ,Electrophysiology ,Amplitude ,Pattern Recognition, Visual ,Receptive field ,Space Perception ,Checkerboard ,business - Abstract
Pattern electroretinograms were recorded to checkerboard stimuli of various check size to both onset-offset pattern and pattern reversal under most similar conditions of contrast and luminance. With onset-offset pattern the amplitude of the p-q and q-r components of the onset response showed a peak for checks of about 20 min of arc (spatial tuning), whereas the offset response was spatially nonselective at high contrast regardless of the luminance level. With pattern reversal the potentials were similar to those after algebraic summation of onset and offset responses both in waveform and check size of peak amplitude at 50 min of arc. From this we conclude that summation of contrast (onset) and luminance (offset) components is responsible for the shift from 20 min of arc (onset tuning) to 50 min of arc (reversal tuning). The study recommends the application of pattern stimuli in an onset-offset mode for studying antagonistic receptive field properties in the human electroretinogram.
- Published
- 1990
- Full Text
- View/download PDF
26. Timing System for J-PARC
- Author
-
M. Yoshii, J. Chiba, F. Tamura, and T. Katoh
- Subjects
Engineering ,business.industry ,Timing system ,Real-time computing ,Linear particle accelerator ,Synchrotron ,law.invention ,Synchronization (alternating current) ,law ,Rapid cycling ,Master clock ,J-PARC ,business ,Computer hardware ,Beam (structure) - Abstract
J-PARC has three accelerators running at the different repetition rates; a 400-MeV linac (50Hz), a 3-GeV rapid cycling synchrotron (RCS, 25Hz), and a 50-GeV synchrotron (MR). The linac and the RCS deliver the beam pluses to the different destinations in each cycle. The destinations are scheduled according to the machine operations. We define two kinds of timing, "scheduled timing" and "synchronization timing" so that the accelerators are operated with proper timing and the beam pulses are transported to the experimental facilities or the next accelerators. The J-PARC complex requires a stable and precise timing system. The system is based on a master clock generated by a synthesizer and the triggers are operated independently of the AC-line frequency. We describe the design of the J-PARC timing system and their configuration, and also present the hardware details.
- Published
- 2006
- Full Text
- View/download PDF
27. EP-1135: Should level IIb nodes be irradiated in definitive radiotherapy for supraglottic cancer?
- Author
-
Kinji Nishiyama, Yoshifumi Kawaguchi, Kunitoshi Yoshino, Naoyuki Kanayama, Koji Konishi, Motoyuki Suzuki, Takashi Fujii, Teruki Teshima, and M. Yoshii
- Subjects
medicine.medical_specialty ,Oncology ,business.industry ,Supraglottic Cancer ,Medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,Radiology ,business ,Definitive radiotherapy - Published
- 2014
- Full Text
- View/download PDF
28. Genetic variation and geographic distribution of porcine reproductive and respiratory syndrome virus in Japan
- Author
-
Hidetoshi Ikeda, Kanako Kato, M. Shimizu, M. Yoshii, Yoshihiro Kaku, and Y. Murakami
- Subjects
China ,Genes, Viral ,Genotype ,Swine ,Porcine Reproductive and Respiratory Syndrome ,Taiwan ,Genome ,Virus ,Arterivirus ,Japan ,Virology ,Genetic variation ,Animals ,Porcine respiratory and reproductive syndrome virus ,Gene ,Genetics ,Swine Diseases ,biology ,Phylogenetic tree ,Geography ,Genetic Variation ,General Medicine ,Porcine reproductive and respiratory syndrome virus ,biology.organism_classification ,Europe ,North America - Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) has two genotypes, the North American-type (NA-type) and the European-type (EU-type), and each genotype is also genetically diverged. We sequenced the ORF5 gene of 30 PRRSVs isolated from 23 prefectures of Japan during 1992 and 1993 and during 2000 and 2001. All of the isolates were of the NA-type. Phylogenetic analysis of the overall NA-type viruses isolated from around the world identified five major genetic clusters. The 1992-1993 Japanese samples belonged to only two genetic clusters, while the 2000-2001 samples included more diverged ORF5 genomes. One genetic cluster, which included 63% (20/32) of Japanese isolates, one Taiwanese isolate and one Chinese isolate, was mainly found in the eastern part of Japan. Another genetic cluster, which was found in various areas around the world, was distributed in the western part of Japan.
- Published
- 2005
29. Radio frequency beam chopping in a surface‐plasma‐type negative‐ion source
- Author
-
Kiyoshi Ikegami, Yoshiharu Mori, M. Yoshii, A. Takagi, Z. Igarashi, Shinji Machida, K. Shinto, and Michikazu Kinsho
- Subjects
Materials science ,Modulation ,Physics::Accelerator Physics ,Biasing ,Plasma ,Radio frequency ,Beam emittance ,Atomic physics ,Instrumentation ,Ion source ,Beam (structure) ,Ion - Abstract
A direct fast‐chopped beam extracted from a surface‐plasma H− ion source is proposed and a preliminary test has been examined. The converter bias voltage is modulated by rf pulses and the extracted H− beam is observed. The direct fast‐chopped H− beam extracted from the ion source has a good response to the modulation of the converter bias voltage, as expected. The chopped H− beam extracted by this method has been injected into the 500 MeV booster synchrotron at KEK‐PS.
- Published
- 1996
- Full Text
- View/download PDF
30. Enterovirus encephalomyelitis in pigs in Japan caused by porcine teschovirus
- Author
-
R. Kozakura, Makoto Haritani, M Yoshii, Y Kaku, R Ikegami, K. Nakamura, and M. Yamada
- Subjects
Swine Diseases ,General Veterinary ,Swine ,Encephalomyelitis ,General Medicine ,Biology ,medicine.disease_cause ,medicine.disease ,biology.organism_classification ,Porcine teschovirus ,Virology ,Disease Outbreaks ,Animals, Newborn ,Japan ,Teschovirus ,medicine ,Enterovirus Infections ,Enterovirus ,Animals ,Paralysis - Published
- 2004
31. Self-contained location detectors with fiber optic gyroscope and its application to the car location system
- Author
-
S. Matsuzaki, M. Yoshii, K. Hirano, S. Maegawa, and Y. Doi
- Subjects
business.industry ,Computer science ,law ,Detector ,Fibre optic sensors ,Electrical engineering ,Gyroscope ,Location systems ,Fibre optic gyroscope ,business ,Signal ,law.invention - Abstract
A location detector with a fiber-optic gyroscope (FOG) and its application to a patrol car location system are described. Several methods of handling the output signal of the FOG as well as other kinds of techniques have been developed. These technologies are also applied to navigation systems used in consumer passenger vehicles. It is believed that an advanced police information system could be constructed by integrating this system with other systems. >
- Published
- 2002
- Full Text
- View/download PDF
32. Design study of antiproton accumulation and deceleration ring in the KEK PS complex
- Author
-
M. Yoshii, N. Tokuda, Y. Ishi, Yoshiharu Mori, and Shinji Machida
- Subjects
Physics ,Proton Synchrotron ,Ring (chemistry) ,Accelerators and Storage Rings ,Synchrotron ,law.invention ,Nuclear physics ,Acceleration ,law ,Antiproton ,Stochastic cooling ,Design study ,Physics::Accelerator Physics ,High Energy Physics::Experiment ,Nuclear Experiment - Abstract
An antiproton accumulation and deceleration ring in the KEK proton synchrotron (KEK PS) complex has been designed. The KEK PS top energy is 12 GeV and it is enough to produce 2 GeV/c antiprotons. As many as 10/sup 5/ of them would be collected each synchrotron cycle, that is 2 second. After stacking and stochastic cooling of the beams, 10/sup 7/ to 10/sup 8/ antiprotons per hour should be available for physics experiments. There are several R&D items such as compression of the nine bunch train in the PS. Preliminary simulation has been done to look at single turn transfer of antiprotons to the proposed ring whose circumference is 1/3 of the PS.
- Published
- 2002
- Full Text
- View/download PDF
33. Automated steering control system design for passenger vehicle in consideration of steering actuator dynamics
- Author
-
Shuichi Adachi, M. Yoshii, and Yukihiro Fujiwara
- Subjects
Vehicle dynamics ,Engineering ,Automatic control ,business.industry ,Control theory ,Control system ,Obstacle avoidance ,ComputerApplications_COMPUTERSINOTHERSYSTEMS ,Control engineering ,Steering wheel ,business ,Visual servoing ,Actuator - Abstract
A control system is described for automated steering systems to prevent traffic accidents. A model of the system is built by integrating a lane model and a vehicle model based on the visual servoing approach. The system is controlled by a guidance controller and an angle controller. The former is designed on the basis of steering actuator dynamics and uncertainties of vehicle parameters, and the latter is designed on the basis of steering wheel dynamics using /spl mu/ synthesis. It is proved that the proposed control system achieves vehicle stability for steering maneuvers such as obstacle avoidance.
- Published
- 2002
- Full Text
- View/download PDF
34. [A case of familial juvenile gouty nephropathy associated with a right renal tumor]
- Author
-
M, Yoshii, T, Yoshimatsu, A, Miyata, A, Murata, K, Nutahara, and E, Higashihara
- Subjects
Adenoma ,Adult ,Diagnosis, Differential ,Arthritis, Gouty ,Nephrosis, Lipoid ,Humans ,Female ,Kidney Neoplasms ,Pedigree ,Uric Acid - Abstract
We present a case of familial juvenile gouty nephropathy which was associated with a right renal tumor that was found incidentally. The patient was a 27-year-old woman who initially presented with acute gouty arthritis at the age of twenty years. Her mother and her sister had been attacked with acute gouty arthritis in their early twenties. Progressive deterioration in the renal function was noted in the three family members who had experienced gouty attack. Her mother was maintained on hemodialysis. As image diagnoses could not rule out malignancy in her right renal tumor, in situ non-ischemic enucleation of the right renal tumor using a microwave tissue coagulator(Microtaze) and a renal biopsy were performed. The pathological diagnosis of the renal tumor was tubulopapillary adenoma, and the renal biopsy showed minimal change in the glomeruli and tubules. The post-operative course was uneventful. The serum creatinine and creatinine clearance before and three months after the operation were 2.4 mg/dl and 2.6 mg/dl, 36.7 ml/min and 32.5 ml/min, respectively. The renal biopsy findings that glomerular and tubular changes were minimal and there was no tissue precipitation of uric acid or sodium urate, and the fact that her renal function decreased progressively despite the treatment of hyperuricemia suggested strongly that renal function might have deteriorated due to unknown factors other than hyperuricemia.
- Published
- 2001
35. The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors
- Author
-
T, Nishizaki, T, Nomura, T, Matuoka, T, Kondoh, G, Enikolopov, G, Enikolopo, K, Sumikawa, S, Watabe, T, Shiotani, and M, Yoshii
- Subjects
Indoles ,Presynaptic Terminals ,Glutamic Acid ,Biology ,Pharmacology ,Neurotransmission ,Receptors, Nicotinic ,Hippocampus ,Synaptic Transmission ,Maleimides ,Cellular and Molecular Neuroscience ,Mecamylamine ,medicine ,Animals ,Enzyme Inhibitors ,Molecular Biology ,Cells, Cultured ,Protein Kinase C ,Long-term potentiation ,Denervation ,Pyrrolidinones ,Rats ,Nicotinic acetylcholine receptor ,Nicotinic agonist ,Nefiracetam ,Excitatory postsynaptic potential ,Neuroscience ,Acetylcholine ,medicine.drug ,Central Nervous System Agents - Abstract
Nefiracetam, a pyrrolidone derivative developed as an anti-dementia drug, persistently potentiated currents through neuronal nicotinic acetylcholine (ACh) receptors (alpha 7, alpha 4 beta 2) expressed in Xenopus oocytes, and the potentiation was blocked by either the selective protein kinase C (PKC) inhibitors, GF109203X and staurosporine, or co-expressed active PKC inhibitor peptide. In primary cultures of rat hippocampal neurons, nefiracetam increased the rate of nicotine-sensitive miniature excitatory postsynaptic currents, without affecting the amplitude, and the increase was inhibited by GF109203X. In addition, the drug caused a marked increase in the glutamate release from electrically stimulated guinea pig hippocampal slices, and the effect was abolished by the nicotinic ACh receptor antagonists, alpha-bungarotoxin and mecamylamine. Nefiracetam induced a long-lasting facilitation of synaptic transmission in both the CAI area and the dentate gyrus of rat hippocampal slices, and the facilitation was inhibited by alpha-bungarotoxin and mecamylamine. Such facilitatory action was still found in the hippocampus with selective cholinergic denervation. The results of the present study, thus, suggest that nefiracetam enhances activity of nicotinic ACh receptors by interacting with a PKC pathway, thereby increasing glutamate release from presynaptic terminals, and then leading to a sustained facilitation of hippocampal neurotransmission. This may represent a cellular mechanism underlying the cognition-enhancing action of nefiracetam. The results also provide the possibility that nefiracetam could be developed as a promising therapeutic drug for senile dementia or Alzheimer's disease. (C) 2000 Elsevier Science B.V. All rights reserved.
- Published
- 2000
36. Functional expression of Fas and Fas ligand on human colonic intraepithelial T lymphocytes
- Author
-
T. Hongo, Noriaki Tanaka, Akio Hizuta, Naoto Urushihara, Hiromi Iwagaki, Youichi Morimoto, Kenta Kobashi, and M Yoshii
- Subjects
Adult ,Cellular immunity ,Fas Ligand Protein ,medicine.drug_class ,Cell Survival ,Colon ,Lymphocyte ,T-Lymphocytes ,chemical and pharmacologic phenomena ,Apoptosis ,030204 cardiovascular system & hematology ,Biology ,Monoclonal antibody ,digestive system ,Biochemistry ,Peripheral blood mononuclear cell ,Fas ligand ,Immunophenotyping ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,medicine ,Humans ,fas Receptor ,Intestinal Mucosa ,Aged ,Membrane Glycoproteins ,Biochemistry (medical) ,Antibodies, Monoclonal ,hemic and immune systems ,Cell Biology ,General Medicine ,T lymphocyte ,Middle Aged ,Molecular biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Immunology ,Leukocyte Common Antigens ,tissues - Abstract
The expression of Fas, a cell surface receptor directly responsible for triggering cell death by apoptosis, and its ligand (FasL) was investigated on both human colonic intraepithelial T lymphocytes (IELs) and peripheral blood mononuclear lymphocytes (PBMLs). FACS analysis indicated that IELs have increased expression of Fas compared with PBMLs, together with the progress activation marker, CD45RO. A discrete fraction of freshly isolated IELs also constitutively expressed FasL, perhaps as a result of recent in vivo activation. Using monoclonal antibody APO2.7, which detects mitochondrial 7A6 antigen specifically expressed by cells undergoing apoptosis, we further investigated the apoptosis-inducing effect of anti-Fas monoclonal antibody (CH11) on both IELs and PBMLs. FACS analysis revealed that CH11 increased the percentage of apoptotic cells, in IELs but not in PBMLs. Culture with anti-FasL monoclonal antibody (4H9) significantly recovered cell viability in IELs, but not in PBMLs. These results indicate that IELs constitutively express both Fas and FasL and that Fas crosslinking generates signals resulting in apoptosis, outlining a potential mechanism involved in intestinal tolerance.
- Published
- 2000
37. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL
- Author
-
T, Okegawa, M, Kinjo, K, Watanabe, H, Noda, M, Kato, A, Miyata, A, Murata, M, Yoshii, K, Nutahara, and E, Higashihara
- Subjects
Immunoenzyme Techniques ,Male ,Predictive Value of Tests ,Area Under Curve ,Prostate ,Prostatic Hyperplasia ,Humans ,Prostatic Neoplasms ,Regression Analysis ,Prostate-Specific Antigen ,Biomarkers ,Aged ,Ultrasonography - Abstract
To compare the ratio of free prostate specific antigen (fPSA), total PSA (tPSA) and complexed PSA (cPSA, measured using a novel immunoassay) with other variables used to detect prostate cancer in patients with intermediate serum PSA levels of 4.1-10.0 ng/mL.From July 1997 to August 1998, 140 consecutive patients were assessed; all had intermediate serum PSA levels and/or abnormal findings on a digital rectal examination. All patients underwent transrectal ultrasonography (TRUS)-guided biopsy, and the prostate and transition zone volumes were determined by TRUS. Free and tPSA were measured using the Tandem-R assay (Hybritech Corp., San Diego, CA). PSA complexed with alpha1-antichymotrypsin (cPSA) was measured using an appropriate assay. The ability of cPSA, free-to-total PSA ratio (f/tPSA), free-to-complexed PSA ratio (f/cPSA), tPSA density of the whole prostate (PSAD), of the transition zone (tPSATZ), and cPSA density of the whole prostate (cPSAD) and of the transition zone (cPSATZ) to improve the power of PSA in detecting prostate cancer was evaluated using receiver operating characteristic (ROC) curves. Results Of the 140 patients, 126 had histologically confirmed benign disease and 14 had prostate cancer. The cPSA alone had better specificity for detecting prostate cancer than had tPSA alone but the difference was not significant. The area under the ROC curve for f/cPSA was larger than those for all other variables. With a 93% sensitivity for detecting prostate cancer, a f/cPSA threshold of 25% would result in fewer unnecessary biopsies (40% f/cPSA specificity) than with all other PSA variables. The difference in the resolution was significant between f/cPSA and tPSA, cPSA, tPSAD and tPSATZ, but not with f/tPSA, cPSAD or cPSATZ. In patients with a prostate volume of30 mL, the cPSATZ showed better specificity for prostate cancer than tPSA alone.Measuring the level of cPSA and its derivatives may provide better differentiation of prostate cancer and benign disease than tPSA alone in patients with a tPSA level of 4.1-10.0 ng/mL.
- Published
- 2000
38. Barrier bucket experiment at the AGS
- Author
-
Y. Sato, M. Fujieda, Yoshihisa Iwashita, Akira Noda, T. Roser, A. Zaltsmann, Chihiro Ohmori, M. Blaskiewicz, Joseph Brennan, Yoshiharu Mori, R. Spitz, M. Yoshii, and Kevin Smith
- Subjects
Physics ,Nuclear and High Energy Physics ,Physics and Astronomy (miscellaneous) ,business.industry ,Surfaces and Interfaces ,Rf system ,Optics ,Sine wave ,Bunches ,Booster (electric power) ,Ferrite (magnet) ,lcsh:QC770-798 ,Thermal emittance ,lcsh:Nuclear and particle physics. Atomic energy. Radioactivity ,Magnetic alloy ,business ,Voltage - Abstract
A barrier bucket experiment with two dedicated barrier cavities was performed at the Brookhaven AGS. One of the barrier cavities was a magnetic alloy (MA)–loaded cavity and the other was a ferrite-loaded cavity. They generated a single sine wave with a peak voltage of 40 kV at a repetition rate of 351 kHz. A barrier rf system was established with these cavities and five bunches from the AGS booster were accumulated. A total of 3×10^{13} protons were stored without beam loss, and were successfully rebunched and accelerated. The longitudinal emittance growth was observed during accumulation by the barrier bucket, the blowup factor of which was about 3. The longitudinal mismatch between the rf bucket and the beam bunch was the main reason for the emittance growth. The potential distortions by beam loading of the ferrite cavity and the overshooting voltage of the MA cavity disturbed the smooth debunching.
- Published
- 1999
39. Longitudinal impedance tuner using new material FINEMET
- Author
-
K. Koba, Kiyoshi Ikegami, Takeshi Toyama, M. Fujieda, Yoshiharu Mori, Dai Arakawa, Chihiro Ohmori, Y. Ishi, S. Shibuya, Shinji Machida, M. Yamamoto, K. Shinto, Tsubasa Watanabe, C. Kubota, Y. Kanai, A. Takagi, Takeichiro Yokoi, T. Uesugi, and M. Yoshii
- Subjects
Materials science ,business.industry ,Proton Synchrotron ,Quarter-wave impedance transformer ,Tuner ,Space charge ,Synchrotron ,law.invention ,Nuclear magnetic resonance ,Optics ,law ,Quadrupole ,Physics::Accelerator Physics ,business ,Instrumentation ,Electrical impedance ,Beam (structure) - Abstract
We designed an impedance tuner consisting of an inductive material, FINEMET, to cancel the space charge impedance in the longitudinal direction. It was installed in the KEK Proton Synchrotron (PS) main ring. We observed the frequency shift of the coherent quadrupole oscillations and inferred the shift of the incoherent synchrotron oscillation. The total reactive impedance can be estimated as the coefficient between the shift and the beam intensity. The measured impedance is reduced from −j2475Ω to −j1182Ω by the impedance tuner which consists of 12 pieces of FINEMET cores. We demonstrated that the space charge impedance is compensated by the impedance tuner. This is the first time for FINEMET to be equipped with an accelerator component. One may think that the characteristics of FINEMET deteriorate under an environment with strong radiation generated by unavoidable beam loss. We have proved that the radiation dose not affect FINEMET even with a total neutron dose of 1.83×1012(n cm−2), which is considered ...
- Published
- 1999
40. Beam Loading Effects On High Gradient Ma-loaded Cavity
- Author
-
M. Fujieda, R. Muramatsu, Yoshiharu Mori, M. Yamamoto, Chihiro Ohmori, Akira Takagi, T. Uesugi, M. Yoshii, Y. Sato, and Y. Hashimoto
- Subjects
Physics ,Cathode ray ,Physics::Accelerator Physics ,Transient (oscillation) ,Laser beam quality ,Magnetic alloy ,Composite material ,Atomic physics ,Tracking (particle physics) ,Particle beam ,XX ,Beam (structure) ,Compensation (engineering) - Abstract
We studied the beam loading effects on the High Gradient Cavity (HGC) loaded with Magnetic Alloy (MA) by multiparticle tracking simulation. The Q-value of the cavity is variable from 0.6 to more than 10. From the view point of multi-bunch effect, it was found that either very high Q-value or low Q-value was preferable to suppress the periodic transient beam loading. The experimental results of the beam loading compensation using an electron beam are also described.
- Published
- 1999
41. High Field-gradient Cavities Loaded With Magnetic Alloys For Synchrotrons
- Author
-
M. Yoshii, M. Fujieda, Y. Sato, Makoto Toda, H. Nakayama, R. Muramatsu, Yoshiharu Mori, K. Noda, Chihiro Ohmori, T. Uesugi, Akira Takagi, Mitsutaka Kanazawa, M. Yamamoto, and E. Ezura
- Subjects
Physics ,Test bench ,business.industry ,Electrical engineering ,XX ,Ferrite core ,Core (optical fiber) ,Acceleration ,Optics ,Harmonic ,Cathode ray ,business ,Beam (structure) ,Voltage - Abstract
Very high field-gradient has become available by a new magnetic alloy (MA)-loaded cavity developed for high intensity proton synchrotrons. The available RF voltage per core is ten times larger than that of the ordinary ferrite core. The maximum voltage of 20 kV has been achieved by the high-field gradient cavity (HGC) of 40 cm in length. Because the intrinsic Q-value of the MA core is low, acceleration without any tuning system also becomes possible. The first beam acceleration test using the HGC has been performed successfully at the HIMAC (Heavy Ion Medical Accelerator in Chiba). Furthermore, the dual harmonic RF and barrier bucket experiments have been carried out. Another advantage of the MA-loaded cavity is that it is easy to compensate the beam loading. The feed forward beam compensation was applied for both HGC on the test bench using an electron beam and MA-loaded cavity installed in the AGS for the barrier bucket experiment. A new development for high-Q HGC using a cut core configuration will be also reported.
- Published
- 1999
42. The First Beam Acceleration Test Using High Gradient Cavity At Himac
- Author
-
Y. Sato, Mitsutaka Kanazawa, H. Nakayama, M. Yamamoto, M. Fujieda, T. Uesugi, R. Muramatsu, K. Noda, Yoshiharu Mori, Chihiro Ohmori, M. Yoshii, and Akira Takagi
- Subjects
Physics ,Acceleration ,Ion accelerators ,Physics::Accelerator Physics ,Heavy ion ,Atomic physics ,Magnetic alloy ,Biomedical equipment ,XX ,Sweep frequency response analysis ,Beam (structure) ,Ion - Abstract
The first beam acceleration test using a high gradient cavity (HGC) loaded with magnetic alloy (MA) cores has been carried out at the HIMAC (Heavy Ion Medical Accelerator in Chiba). Acceleration of heavy ions, which required a wide frequency sweep from 1 MHz to 8 MHz, was successfully carried out without resonant frequency tuning.
- Published
- 1999
43. Impedance budget and beam instabilities of the JHF 50-GeV proton synchrotron
- Author
-
M. Yoshii and Y. Mori
- Subjects
Nuclear physics ,Physics ,Ion beam ,law ,Proton Synchrotron ,Particle accelerator ,Atomic physics ,Particle beam ,Electrical impedance ,Instability ,Beam (structure) ,law.invention - Published
- 1999
- Full Text
- View/download PDF
44. Multi-orbit synchrotron with FFAG focusing for acceleration of high intensity hadron beams
- Author
-
K. Koba, M. Yoshii, S. Ishi, Shinji Machida, Satoru Yamada, K. Umezawa, R. Muramatsu, Y. Sato, Koji Noda, T. Uesugi, M. Fujieda, I. Sakai, Y. Yamamoto, R. Ueno, M. Matoba, M. Kanazawa, Yoshiharu Mori, Chihiro Ohmori, and Toshikazu Adachi
- Subjects
Physics ,Proton ,XX ,Synchrotron ,law.invention ,Magnetic field ,Nuclear physics ,law ,Muon collider ,Physics::Accelerator Physics ,Neutron ,Radio frequency ,EMMA ,Spallation Neutron Source - Abstract
A multi-orbit synchrotron (MOS) with fixed field alternating gradient (FFAG) focusing is attractive for acceleration of high intensity hadron beams because acceleration cycle could be increased. The magnetic field of MOS is static, therefore, the repetition rate of acceleration could be increased more than 10 times larger than that of ordinary rapid cycling synchrotron (RCS) if an efficient high voltage RF accelerating system becomes available. Recently, a new type of high gradient RF cavity (HGC) using high permeability magnetic alloy (MA) has been developed and MOS with FFAG focusing becomes very promising. In order to clarify the feasibility of rapid cycling MOS (RCMOS) experimentally, proof-of-principle (POP) machine, which accelerates protons up to 1 MeV with 1 kHz repetition, is under development. We have also made several designs on high intensity proton accelerators with RCMOS for various applications such as an accelerator driven system (ADS) as an energy breeder, a spallation neutron source and a proton driver for a muon collider.
- Published
- 1999
- Full Text
- View/download PDF
45. Magnetic Alloy Loaded Rf Cavity For Barrier Bucket Experiment At The Ags
- Author
-
Chihiro Ohmori, T. Roser, Y. Sato, M. Fujieda, M. Yoshii, Yoshiharu Mori, M. Blaskiewicz, Joseph Brennan, R. Spitz, Yoshihisa Iwashita, A. Zaltsmann, Kevin Smith, and Akira Noda
- Subjects
Bunches ,Materials science ,business.industry ,RF power amplifier ,Electrical engineering ,Rf cavity ,Ferrite (magnet) ,Optoelectronics ,Magnetic alloy ,business ,XX ,Electrical impedance ,Voltage - Abstract
A magnetic alloy (MA) loaded cavity which was developed by KEK was used for the barrier bucket experiment at the AGS. The MA loaded cavity could generate a single sine-wave of 40 kV with less RF power than a ferrite loaded cavity because of its broad-band impedance. In order to reduce the voltage induced by beam, the feedforward system was applied and the beam loading was compensated. With the barrier bucket scheme, five bunches were transferred successfully. Total of 3/spl times/10/sup 13/ protons were accumulated without beam loss. They were re-bunched by the accelerating cavities and accelerated.
- Published
- 1999
46. [Detection of parafoveal scotoma by multifocal electroretinograms]
- Author
-
K, Matsuno, M, Yoshii, S, Okisaka, T, Wakaguri, Y, Kikuchi, K, Yanashima, and F, Sakemi
- Subjects
Male ,Retinal Degeneration ,Electroretinography ,Humans ,Visual Field Tests ,Middle Aged ,Scotoma - Abstract
We investigated the relation between multifocal electroretinograms (M-ERGs) and artificial parafoveal scotoma. M-ERGs were recorded from normal subjects using a circular piece of black paper attached to a monitor. Lower response density around the 10 to 15 degree parafovea region was not observed up to 3 degree scotoma (visual angle), but was detected above 5 degree scotoma in field topography of M-ERGs. The shape of the scotoma in field topography was not circular but somewhat oval. The results from two cases of parafoveal retinal degeneration were in good accordance with this basic study in normal subjects. We proved that detection of parafoveal scotoma by M-ERG is limited in comparison with the results obtained by automated static perimetry.
- Published
- 1998
47. [Mitochondrial benzodiazepine receptors (MBR) in association with neurological disorders]
- Author
-
M, Yoshii, Y, Nakamoto, S, Watabe, G, Mugishima, H, Habu, T, Shiotani, and T, Nabeshima
- Subjects
Benzodiazepinones ,Mice ,Seizures ,Animals ,Convulsants ,Receptors, GABA-A ,Mice, Mutant Strains ,Mitochondria - Abstract
Ro 5-4864, a specific agonist of the peripheral-type benzodiazepine receptor (PBR), elicited convulsions 2.6 times more potently in EL mice (an animal model of epilepsy) than in DDY mice (control animal). A binding assay revealed a 50% higher density of [3H] Ro 5-4864 binding sites in the mitochondrial fraction (i.e., mitochondrial benzodiazepine receptors; MBR) of the brain tissues in EL mice as compared with DDY mice. On an elevated plus-maze, EL mice showed fear responses similar to those increased in DDY mice after PBR stimulation, suggesting a hyperfunction of MBR underlying the abnormal behaviors of EL mice. In fluorometric studies using NG108-15 cells, Ro 5-4864 depolarized mitochondrial membranes and, possibly as a consequence of this, raised intracellular Ca2+. Finally, we propose that MBR could be a major target of therapy for various neurological disorders, so drugs such as "mitochondrial membrane stabilizers" should be developed.
- Published
- 1998
48. [Successful treatment with end-to-end ureteral anastomosis for ureteral avulsion caused by abdominal blunt trauma: a case report]
- Author
-
H, Mibu, Y, Kagebayashi, M, Tanaka, S C, Kim, M, Yoshii, K, Fujimoto, S, Ozono, and Y, Hirao
- Subjects
Adult ,Male ,Anastomosis, Surgical ,Humans ,Urologic Surgical Procedures ,Abdominal Injuries ,Plastic Surgery Procedures ,Ureter ,Wounds, Nonpenetrating - Abstract
Avulsion of ureter without renal injury is rarely caused by blunt trauma, only 28 cases having been reported in Japan. A 33-year-old male was admitted to our hospital 1 month after blunt abdominal trauma at work. He complained of left flank pain and macroscopic hematuria. Under the suspicion of renal or ureteral injury, drip infusion urography and abdominal computerized tomography revealed an extravasation from the left upper ureter and urinoma formation in the retroperitoneal cavity. In order to reduce the inflammation, the urinoma was drained. The retrograde pyelogram revealed complete obstruction at the left upper ureter, 20 cm from the left ureteral orifice. Urinary tract reconstruction, end-to-end ureteral anastomosis, was performed under the diagnosis of left ureteral avulsion. Drip infusion urography revealed normal ureteral healing without stricture formation at 2 years after reconstruction.
- Published
- 1998
49. Differential interactions of the C terminus and the cytoplasmic I-II loop of neuronal Ca2+ channels with G-protein alpha and beta gamma subunits. II. Evidence for direct binding
- Author
-
T, Furukawa, R, Miura, Y, Mori, M, Strobeck, K, Suzuki, Y, Ogihara, T, Asano, R, Morishita, M, Hashii, H, Higashida, M, Yoshii, and T, Nukada
- Subjects
Neurons ,Cytoplasm ,Base Sequence ,Xenopus ,Molecular Sequence Data ,Oligonucleotides, Antisense ,Recombinant Proteins ,Calcium Channel Agonists ,GTP-Binding Proteins ,Animals ,Amino Acid Sequence ,Calcium Channels ,Rabbits ,DNA Primers ,Protein Binding - Abstract
The present study was designed to obtain evidence for direct interactions of G-protein alpha (Galpha) and beta gamma subunits (Gbeta gamma) with N- (alpha1B) and P/Q-type (alpha1A) Ca2+ channels, using synthetic peptides and fusion proteins derived from loop 1 (cytoplasmic loop between repeat I and II) and the C terminus of these channels. For N-type, prepulse facilitation as mediated by Gbeta gamma was impaired when a synthetic loop 1 peptide was applied intracellularly. Receptor agonist-induced inhibition of N-type as mediated by Galpha was also impaired by the loop 1 peptide but only when applied in combination with a C-terminal peptide. For P/Q-type channels, by contrast, the Galpha-mediated inhibition was diminished by application of a C-terminal peptide alone. Moreover, in vitro binding analysis for N- and P/Q-type channels revealed direct interaction of Galpha with C-terminal fusion proteins as well as direct interaction of Gbeta gamma with loop 1 fusion proteins. These findings define loop 1 of N- and P/Q-type Ca2+ channels as an interaction site for Gbeta gamma and the C termini for Galpha.
- Published
- 1998
50. Differential interactions of the C terminus and the cytoplasmic I-II loop of neuronal Ca2+ channels with G-protein alpha and beta gamma subunits. I. Molecular determination
- Author
-
T, Furukawa, T, Nukada, Y, Mori, M, Wakamori, Y, Fujita, H, Ishida, K, Fukuda, S, Kato, and M, Yoshii
- Subjects
Neurons ,Cytoplasm ,Base Sequence ,Oligodeoxyribonucleotides ,GTP-Binding Proteins ,Xenopus ,Animals ,Calcium Channels ,Rabbits ,Recombinant Proteins - Abstract
Interactions of G-protein alpha (Galpha) and beta gamma subunits (Gbeta gamma) with N- (alpha1B) and P/Q-type (alpha1A) Ca2+ channels were investigated using the Xenopus oocyte expression system. Gi3alpha was found to inhibit both N- and P/Q-type channels by receptor agonists, whereas Gbeta1 gamma2 was responsible for prepulse facilitation of N-type channels. L-type channels (alpha1C) were not regulated by Galpha or Gbeta gamma. For N-type, prepulse facilitation mediated via Gbeta gamma was impaired when the cytoplasmic I-II loop (loop 1) was deleted or replaced with the alpha1C loop 1. Galpha-mediated inhibitions were also impaired by substitution of the alpha1C loop 1, but only when the C terminus was deleted. For P/Q-type, by contrast, deletion of the C terminus alone diminished Galpha-mediated inhibition. Moreover, a chimera of L-type with the alpha1B loop 1 gained Gbeta gamma-dependent facilitation, whereas an L-type chimera with the N- or P/Q-type C terminus gained Galpha-mediated inhibition. These findings provide evidence that loop 1 of N-type channels is a regulatory site for Gbeta gamma and the C termini of P/Q- and N-types for Galpha.
- Published
- 1998
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.